Compares two surgeries for cecal cancer in adults
Compares ileocecal resection with D3 lymphadenectomy against standard right hemicolectomy for cecal cancer.
Plain-language title generated from the registry record
Registry title: Local Cecal Cancer - Optimization of Surgical Treatment
Key facts
- Where
- Moscow, RussiaSee the site
Where in Russia
- Moscow Clinical Scientific CenterMoscow, RussiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Moscow Clinical Scientific Center
- Trial code
- NCT06121089
- Record updated
- 18 November 2023
- Original description
The purpose of this study is to determine the clinical efficacy, safety, and oncologic outcomes of ileocecal resection (ICR) with D3 lymphadenectomy compared to standard right hemicolectomy(RHC) for cecal cancer.Read full original descriptionShow less
Study of the Oncological Outcomes of Ileocecal Resection With D3 for Cecal Cancer
The purpose of this study is to determine the clinical efficacy, safety, and oncologic outcomes of ileocecal resection (ICR) with D3 lymphadenectomy compared to standard right hemicolectomy(RHC) for cecal cancer.
Inclusion: At least 18 years of age; ECOG status 0-2; Histologically confirmed adenocarcinoma of the colon; Clinical stage T1-3; N+; M0; The physical status from ASA classification I, II, III or IV; Written informed consent.
Exclusion: Neoadjuvant chemotherapy; Medical contraindications for surgical treatment; Synchronous or metachronous malignancy; Complicated tumor: obstruction, perforation; Medical or psychiatric conditions that compromise the patient's ability to give informed consent or comply with the study protocol; Locally-advanced tumor (T>3); Presence of distant metastases (M1); Pregnancy or breast feeding.